Thomas Steckler, M.D., is Associate Director, Bioresearch and Quality and Compliance, Quality Planning & Strategy, Animal Welfare Strategy Lead, at Janssen Pharmaceutica NV, Johnson & Johnson, based in Beerse, Belgium.
Dr. Steckler earned his medical degree from the Free University of Berlin, Germany and received a doctorate degree in medicine at the Free University of Berlin in collaboration with the Department of Neuropsychopharmacology, Schering AG. He worked as a postdoc at the MRC Neurochemical Pathology Unit, Newcastle upon Tyne, UK, then as a group leader at the Max Planck Institute of Psychiatry in Munich, Germany. He has been at Janssen Pharmaceutica in Belgium for almost 20 years. There he has served in different functions, initially in the area of neuroscience drug discovery, then in the quality organization. Dr. Steckler is the EFPIA (European Federation of Pharmaceutical Industries and Associations) lead of the EQIPD (European Quality In Preclinical Data) project consortium, which is supported by the Innovative Medicines Initiative. To contact EQIPD see details below.